A large randomised controlled trial of thrombolysis with intravenous recombinant tissue plasminogen activator (rt-PA) for acute ischaemic stroke within 6 hours

IST-3 is now the world's largest thrombolysis for stroke trial with over 1300 patients - Congratulations to all collaborators!!

Improve your acute stroke imaging interpretative skillsImprove your acute stroke imaging interpretative skills!

See- BASP CT Training Series  

ACCESS Study - The Acute Cerebral CT Evaluation Study

**NEW!     Implications of ECASS-3 results for IST-3
 

October IST-3 Newsletter
 

Presentation by Joanna Wardlaw - Update of Cochrane Systematic Review
 to include ECASS-3
 

Presentation by Peter Sandercock at IST-3 Collaborators Meeting
(at WSC 2008 in Vienna) and report of IST-3 DMC
 

Register here to see and hear the November 3rd IST-3 webcast
(Steering Committee Report & Recruitment Update)

 

Click here to see the slides (no soundtrack)

 

*************************************************************************

Final Announcement and Invitation to
 Stroke Symposium - from genes to acute care

Stockholm January 29th-30th 2009

 see IST-3 Sweden for program

*************************************************************************


The IST-3 protocol is now published in full at BMC Trials,
as an open-access publication, at http://www.trialsjournal.com/content/9/1/37
Please feel free to link to it from your personal or institutional website

 

 

CONTACT

The IST-3 Trial Co-ordinating Centre
Neuroscience Trial Unit
Bramwell Dott Building
Western General Hospital
Crewe Road
Edinburgh, UK
EH4 2XU

Tel:+44 (0)131 537 2793
Fax: +44 (0)131 332 5150
ist3@skull.dcn.ed.ac.uk

Our WebServer is maintained by David Perry: dnap@skull.dcn.ed.ac.uk
This site is maintained by Vera Soosay: ves@skull.dcn.ed.ac.uk
and was last update on 06th April 2007